Bruce Colwill

Currently holds a position at InMed Pharmaceuticals Inc

1.0

1.0

Position	Company	Period
Chief Financial Officer	InMed Pharmaceuticals Inc	Aug. 9, 2019 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2022-01-24	2022-01-24	InMed Pharmaceuticals Inc (INM)	B Purchase	58,502 -24.3% 326.57 US$2,944,665	58,502 -24.3%	326.57	US$2,944,665
2021-09-29	2021-09-28	InMed Pharmaceuticals Inc (INM)	B Purchase	28,005 +4.2% 93.10 US$4,356,867	28,005 +4.2%	93.10	US$4,356,867